Do You Have a TDXD or Pembrychemo?

There's a lot of debate about this. And I could easily see this going into a Neil Love point counterpoint sessions when you have investigators debating. But there's a score thought to keep the trial simple. Not to ask too many questions in one trial. Just keep it simple. Get a straight answer. Otherwise you get too many confounders and so forth. The TDXD arm is just TDXD, not with an I.O. There's not a third arm. Yeah, that'll be really interesting. When do you think we're going to get a readout on that? So I'm hoping to so I presented the trial design last year in Asco.